
Cofactor Genomics YC 申请
Cofactor Genomics 在 Summer 2015 批次的 Y Combinator 中作为一家 Healthcare 公司进行过。以下是:公司做什么、谁创立了它,以及其 YC 申请,按照真实 YC 表格逐题重建。
- YC 批次
- Summer 2015
- 行业
- HealthcareDiagnostics
- 团队规模
- 13
- 状态
- Active
- 已发布
- 2015
创始人
Dave MessinaFounder/COO
Jarret GlasscockFounder/CTO
Cofactor Genomics 做什么
Cofactor uses RNA and Predictive Immune Modeling to build better biomarkers and improve patient outcomes. Led by Jarret Glasscock and a group of expert human genome scientists,Cofactor has built a new category of diagnostic technology powered by unique and powerful RNA data models built on terabytes of data. The team recently had their technology validation peer-reviewed by the organizations that set standards for diagnostic technology (CAP, AMP) and is publishing in the Journal of Molecular Diagnostics. In addition, the team made news when Cancer Physicians who sit on the committee for patient treatment guidelines (NCCN) presented a clinical study using Cofactor’s technology showing superiority in predicting the patients who will respond to immunotherapy. This initial application is an acute problem recognized widely in the rapidly developing immunotherapy industry and represents north of a billion dollar TAM. After a number of recent key milestones, the team is taking the technology more broadly to 50% of cancers diagnosed in the US. Current investors include Menlo Ventures, DCVC, and Ascension Ventures (this last investor representing the funding arm for 13 National U.S. Healthcare Systems).
Cofactor Genomics 的 YC 申请,重建版
Y Combinator 申请
Cofactor Genomics,Summer 2015 期。来自公开数据的真实申请问题解答。
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
Cofactor Genomics
Cofactor closes the precision medicine gap with predictive diagnostics
We build diagnostic tests using RNA sequencing and predictive immune modeling to create biomarkers that better predict patient responses, mainly for cancer immunotherapy. Our product helps doctors select which patients will respond to specific treatments, improving outcomes where current diagnostics fall short.
We live and work in St. Louis, Missouri, and the company remains based there.
St. Louis grounds us with access to strong genomics talent and a supportive healthcare ecosystem, including relationships with national healthcare systems. We don't see a need to relocate right now.
21 更多回答 在完整申请中
Founders, Progress, Idea, Equity, Curious, Batch Preference 包含在完整版中。创建免费账户即可在 YC Insights 中打开,紧邻每个其他 YC 批次。
常见问题解答
这是 Cofactor Genomics 的真实 YC 申请吗?
不是。Y Combinator 对提交的申请保密。这是重建版:使用 Cofactor Genomics 的公开数据(发布笔记、创始人背景、产品描述)回答真实的 YC 表格问题。它展示了像 Cofactor Genomics 这样的公司会如何向 YC 自我介绍,而不是他们提交的文本。
Cofactor Genomics 是哪个 YC 批次的?
Cofactor Genomics 是 Y Combinator Summer 2015 批次的成员。
谁创立了 Cofactor Genomics?
Cofactor Genomics 由 Dave Messina, Jarret Glasscock 创立。
Cofactor Genomics 做什么?
Cofactor closes the precision medicine gap with predictive diagnostics
如何阅读完整的重建申请?
创建免费的 Round Funded 账户。YC Insights 中包含 Cofactor Genomics 的完整 26 个问题的版本,以及其他所有 YC 批次的公司信息。